Germline mutations in the phosphatase and tensin homolog (PTEN) protein have been shown to be associated with diverse clinical phenotypes, including cancers and autism spectrum disorder, due to the structural defects caused by the mutations (37, 51, 69). The gene discussed is PTEN; the disease is autism spectrum disorder.